Erytech Pharma: BVF Partners falls below 5% threshold
On December 28, the declaring party had crossed the 5% voting rights threshold and held, at that date, 5.20% of the capital and 4.97% of the voting rights of this biopharmaceutical company. These threshold crossings resulted from the sale of shares on the market.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction